RTOG Foundation, Inc.
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- RTOG Foundation, Inc.
- Target Recruit Count
- 188
- Registration Number
- NCT03809000
- Locations
- ๐บ๐ธ
USC Medical Center - Los Angeles County, Los Angeles, California, United States
๐บ๐ธUniversity of Southern California, Los Angeles, California, United States
๐บ๐ธSutter Roseville Medical Center, Roseville, California, United States
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
- Conditions
- Interventions
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 712
- Registration Number
- NCT03722355
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- RTOG Foundation, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT03546582
- Locations
- ๐บ๐ธ
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
๐บ๐ธUniversity of Arizona Cancer Center - North Campus, Tucson, Arizona, United States
๐บ๐ธOhio State University, Columbus, Ohio, United States
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
- Conditions
- Interventions
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- RTOG Foundation, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02768558
- Locations
- ๐บ๐ธ
Virginia Mason, Seattle, Washington, United States
๐บ๐ธMount Sinai Cancer Research Center, Miami Beach, Florida, United States
๐บ๐ธReading Hospital/McGlinn Cancer Institute, West Reading, Pennsylvania, United States
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- RTOG Foundation, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02764593
- Locations
- ๐บ๐ธ
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
๐บ๐ธOhio State University, Columbus, Ohio, United States
๐บ๐ธUPMC - Shadyside Hospital, Pittsburgh, Pennsylvania, United States
Optuneยฎ Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- RTOG Foundation, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT02743078
- Locations
- ๐บ๐ธ
University of California Irvine, Chao Family Comprehensive Cancer Center, Orange, California, United States
๐บ๐ธCleveland Clinic Foundation, Cleveland, Ohio, United States
๐บ๐ธEmory University, Atlanta, Georgia, United States
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 330
- Registration Number
- NCT01993810
- Locations
- ๐บ๐ธ
MD Anderson Regional Care Center-Sugar Land, Sugar Land, Texas, United States
๐บ๐ธUniversity of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
๐บ๐ธMassachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-10-01
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT01953952
- Locations
- ๐บ๐ธ
Stanford University Hospitals and Clinics, Stanford, California, United States
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
- First Posted Date
- 2013-08-13
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 20
- Registration Number
- NCT01921751
- Locations
- ๐บ๐ธ
Radiation Oncology Associates PC, Fort Wayne, Indiana, United States
๐บ๐ธUniversity of Rochester, Rochester, New York, United States
๐บ๐ธEmory University/Winship Cancer Institute, Atlanta, Georgia, United States
Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC
- Conditions
- Interventions
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 44
- Registration Number
- NCT01753414
- Locations
- ๐จ๐ณ
Shanghai Cancer Center/Fudan University, Shanghai, China
๐จ๐ณChinese Academy of Medical Science, Beijing, China
๐จ๐ณShandong Cancer Hospital, Jinan, Shangdong, China